Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
17.65
-0.18 (-1.01%)
Nov 5, 2024, 10:44 AM EST - Market open

Silence Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
826672547715611-
Upgrade
Market Cap Growth
347.10%22.71%-23.44%17.04%--
Upgrade
Enterprise Value
646600448612549-
Upgrade
Last Close Price
17.8317.3715.2523.8922.00-
Upgrade
PE Ratio
--11.69-10.06-13.27-13.49-
Upgrade
PS Ratio
32.8920.7825.9642.5381.67-
Upgrade
PB Ratio
5.8730.9320.5861.9349.39-
Upgrade
P/FCF Ratio
-24.05-13.39-9.9696.09-39.64-
Upgrade
P/OCF Ratio
-24.13-13.40-9.9977.58-41.52-
Upgrade
EV/Sales Ratio
28.5418.5721.2336.4073.34-
Upgrade
EV/EBITDA Ratio
-11.39-9.57-7.69-9.92-13.18-
Upgrade
EV/EBIT Ratio
-11.31-9.50-7.65-9.86-12.97-
Upgrade
EV/FCF Ratio
-18.82-11.96-8.1582.24-35.60-
Upgrade
Debt / Equity Ratio
0.000.020.020.020.040.01
Upgrade
Debt / FCF Ratio
-0.01-0.01-0.010.02-0.030.17
Upgrade
Asset Turnover
0.130.250.170.140.080.01
Upgrade
Quick Ratio
9.154.104.035.412.773.84
Upgrade
Current Ratio
9.834.564.415.692.993.88
Upgrade
Return on Equity (ROE)
-64.28%-221.19%-264.65%-448.22%-217.21%-69.98%
Upgrade
Return on Assets (ROA)
-21.54%-30.80%-29.82%-31.44%-29.33%-33.45%
Upgrade
Return on Capital (ROIC)
-48.36%-155.63%-194.80%-317.04%-126.58%-50.52%
Upgrade
Earnings Yield
-6.07%-8.20%-8.91%-7.46%-7.27%-
Upgrade
FCF Yield
-4.53%-7.47%-10.04%1.04%-2.52%-
Upgrade
Buyback Yield / Dilution
-18.35%-15.21%-8.58%-8.78%-8.85%-6.85%
Upgrade
Total Shareholder Return
-18.35%-15.21%-8.58%-8.78%-8.85%-6.85%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.